|Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: An open-label, multi-arm, non-randomised, multicentre, phase 2 trial|
AG Sacco, R Chen, FP Worden, DJL Wong, D Adkins, P Swiecicki, ...
The Lancet Oncology 22 (6), 883-892, 2021
|Role of e-cigarettes and pharmacotherapy during attempts to quit cigarette smoking: The PATH Study 2013-16|
JP Pierce, T Benmarhnia, R Chen, M White, DB Abrams, BK Ambrose, ...
PloS one 15 (9), e0237938, 2020
|Use of e-cigarettes and other tobacco products and progression to daily cigarette smoking|
JP Pierce, R Chen, EC Leas, MM White, S Kealey, MD Stone, ...
Pediatrics 147 (2), 2021
|Use of electronic cigarettes to aid long-term smoking cessation in the United States: prospective evidence from the PATH Cohort Study|
R Chen, JP Pierce, EC Leas, MM White, S Kealey, DR Strong, ...
American journal of epidemiology 189 (12), 1529-1537, 2020
|Effectiveness of e-cigarettes as aids for smoking cessation: evidence from the PATH Study cohort, 2017–2019|
R Chen, JP Pierce, EC Leas, T Benmarhnia, DR Strong, MM White, ...
Tobacco Control, 2022
|Incidence of cigarette smoking relapse among individuals who switched to e-cigarettes or other tobacco products|
JP Pierce, R Chen, S Kealey, EC Leas, MM White, MD Stone, ...
JAMA network open 4 (10), e2128810-e2128810, 2021
|Effect of graphic warning labels on cigarette packs on US smokers’ cognitions and smoking behavior after 3 months: a randomized clinical trial|
DR Strong, JP Pierce, K Pulvers, MD Stone, A Villaseñor, M Pu, ...
JAMA network open 4 (8), e2121387-e2121387, 2021
|An open label, nonrandomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell …|
AG Sacco, R Chen, D Ghosh, DJL Wong, FP Worden, D Adkins, E Pittman, ...
Journal of Clinical Oncology 37 (15_suppl), 6033-6033, 2019
|An open-label, non-randomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients (pts) with recurrent/metastatic (R/M) head and neck …|
A Sacco, R Chen, D Ghosh, F Worden, DJ Wong, D Adkins, PL Swiecicki, ...
2020 Multidisciplinary Head and Neck Cancers Symposium (February 27-29, 2020), 2020
|An open-label, non-randomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous …|
AG Sacco, K Messer, A Natsuhara, R Chen, DJL Wong, FP Worden, ...
Journal of Clinical Oncology 36 (15_suppl), 6037-6037, 2018
|Real-World exposure to graphic warning labels on cigarette packages in US smokers: the CASA randomized trial protocol|
JP Pierce, DR Strong, MD Stone, A Villaseñor, CV Dimofte, EC Leas, ...
Contemporary clinical trials 98, 106152, 2020
|E-cigarettes and cessation: the introduction of substantial bias in analyses of PATH Study|
JP Pierce, EC Leas, T Benmarhnia, SB McMenamin, DR Strong, R Chen, ...
Nicotine and Tobacco Research 23 (5), 876-877, 2021
|Assessing oximetry response to chimeric antigen receptor T-cell therapy against glioma with 19F MRI in a murine model|
F Chapelin, BI Leach, R Chen, D Lister, K Messer, H Okada, ET Ahrens
Radiology: Imaging Cancer 3 (1), 2021
|Abstract P3-10-18: Phase 1b trial of cirmtuzumab and paclitaxel for locally advanced, unresectable and metastatic breast cancer|
RA Shatsky, RB Schwab, TL Helsten, EI Pittman, R Chen, JB Breitmeyer, ...
Cancer Research 80 (4_Supplement), P3-10-18-P3-10-18, 2020
|Daily E-cigarette Use and the Surge in JUUL Sales: 2017–2019|
JP Pierce, J Zhang, LE Crotty Alexander, EC Leas, S Kealey, MM White, ...
|Abstract CT134: A phase I study of avelumab, palbociclib, and cetuximab (APC) in recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC)|
KA Gold, A Sacco, J Bykowski, G Daniels, E Pittman, K Messer, R Chen, ...
Cancer Research 81 (13_Supplement), CT134-CT134, 2021
|Alvimopan for enhanced gastrointestinal recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a randomized controlled trial|
JM Baumgartner, R Chen, K Messer, J Veerapong, KJ Kelly, ...
Journal of the American College of Surgeons 235 (5), 693-701, 2022
|Patient Blood Type Is Associated With Response to Immune Checkpoint Blockade in Metastatic Cancer|
R Chen, K Hakimi, X Zhang, K Messer, SP Patel
The oncologist 27 (9), e739-e747, 2022
|Phenotypic and Proliferative Analysis of T Cell and Monocyte Populations in Patients with Intermediate/High/Very High-Risk MDS Compared to Age-Matched Healthy Donors|
H Fields, V Ferrari, A Tarke, RGS Tsai, T Luger, C McCarthy, R Chen, ...
Blood 136, 25-26, 2020
|A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma|
MJ Dennis, AG Sacco, Y Qi, J Bykowski, E Pittman, R Chen, K Messer, ...
Oral Oncology 135, 106219, 2022